Ozempic picks up the Wegovy slack for Novo Evaluate Pharmasource Post navigation OrsoBio Acquires Phase 2-Ready, Selective ACC2 Inhibitor from Shionogi & Co., Ltd. for the Treatment of Type 2 Diabetes – Business Wire Being a Night Owl Spikes Your Risk of Chronic Disease — Best Life – Best Life